- The debranching enzyme has two distinct catalytic activities: a 4-α-D-glucanotransferase and an amylo-α-1,6-glucosidase. A genetic defect eliminates only the glucosidase activity while leaving the transferase activity intact. What would be the primary structural characteristic of the glycogen that accumulates in affected individuals?
Answer: Highly branched molecules with numerous single glucose residues remaining at the α-1,6 branch points.
Glycogen phosphorylase stops four residues from a branch point. The transferase activity of the debranching enzyme moves three of these residues to a nearby chain. This leaves a single glucose attached by an α-1,6 bond. The amylo-α-1,6-glucosidase activity is required to cleave this bond. If this activity is missing, degradation halts at this point, resulting in an accumulation of glycogen with many single-glucose stubs at the former branch points (a type of limit dextrin).
- Glycogen synthase cannot directly use glucose-1-phosphate to extend a glycogen chain; instead, glucose must first be "activated" by its attachment to UTP to form UDP-glucose. What is the primary thermodynamic reason for this activation step?
Answer: The cleavage of the high-energy phosphoester bond in UDP-glucose makes the subsequent transfer of the glucosyl unit to glycogen exergonic.
The formation of a glycosidic bond is an energetically unfavorable process. By 'activating' glucose as UDP-glucose, the cell links it via a high-energy bond. The subsequent cleavage of this bond during the glycogen synthase reaction releases free energy (ΔG < 0), which drives the formation of the glycosidic bond, making the overall process of glycogen chain elongation thermodynamically favorable. UDP is an excellent leaving group in this context.
- During a short, high-intensity sprint, a skeletal muscle cell experiences a rapid drop in ATP and a concurrent rise in AMP. How do these changes in metabolite concentrations directly influence the activity of muscle glycogen phosphorylase?
Answer: High AMP levels allosterically activate the typically inactive, dephosphorylated form (phosphorylase b), promoting rapid glycogenolysis.
In muscle, the dephosphorylated, typically less active form of glycogen phosphorylase (phosphorylase b) can be allosterically activated by high levels of AMP. This allows the muscle to rapidly mobilize glucose from glycogen in response to an immediate energy demand (low ATP/high AMP), even before hormonal signals (like epinephrine) have had time to cause its phosphorylation to the more active 'a' form.
- An investigator is studying the regulation of glycogen metabolism in muscle cells. She adds epinephrine to cultured myocytes and observes increased phosphorylase kinase activity within 2 minutes. She then adds a protein kinase A inhibitor (H89) and notices that phosphorylase kinase activity remains elevated for at least 10 more minutes. What is the most likely explanation for the sustained phosphorylase kinase activity?
Answer: Epinephrine activates both PKA and calcium signaling pathways, and phosphorylase kinase remains active through its calcium-calmodulin regulatory mechanism
Phosphorylase kinase can be activated by two mechanisms: phosphorylation by PKA (through cAMP) and calcium-calmodulin binding. Epinephrine in muscle activates both pathways - cAMP/PKA signaling and calcium release. Even when PKA is inhibited, elevated calcium levels continue to activate phosphorylase kinase through the calcium-calmodulin mechanism. Choice A is incorrect because H89 is membrane permeable and effectively inhibits PKA. Choice B is partially correct about calcium but misses that this is a normal dual regulatory mechanism. Choice D is incorrect because even though inhibitor-1 may be phosphorylated, this doesn't explain sustained activation when PKA is blocked - the calcium mechanism does.
- The synthesis of glycogen from glucose-6-phosphate involves the formation of UDP-glucose from glucose-1-phosphate and UTP. Considering the subsequent hydrolysis of pyrophosphate (PPi), what is the net energetic cost, in terms of high-energy phosphate bond equivalents, to incorporate one molecule of glucose into a growing glycogen chain?
Answer: Two ATP equivalents, due to the hydrolysis of both UTP and pyrophosphate.
The reaction catalyzed by UDP-glucose pyrophosphorylase is: G1P + UTP ⇌ UDP-glucose + PPi. This consumes one high-energy bond. The pyrophosphate (PPi) is rapidly hydrolyzed by pyrophosphatase to 2 Pi, an exergonic reaction that consumes a second high-energy phosphate bond equivalent. This hydrolysis makes the overall process of UDP-glucose formation irreversible and costs a total of two ATP equivalents.
- During the fed state, insulin activates protein phosphatase 1 (PP1) in liver cells, leading to dephosphorylation of key regulatory enzymes. A student observes that both glycogen synthase and acetyl-CoA carboxylase are dephosphorylated, but notices that hormone-sensitive lipase is not affected by PP1 activation. What is the most likely explanation for this selective dephosphorylation pattern?
Answer: PP1 activity is compartmentalized through targeting subunits that direct it to glycogen particles and fatty acid synthesis complexes but not lipolysis enzymes
PP1 activity is directed to specific substrates through targeting subunits that localize the phosphatase to particular cellular locations and enzyme complexes. In liver, PP1 is targeted to glycogen particles (affecting glycogen synthase and phosphorylase) and lipogenic enzyme complexes (affecting acetyl-CoA carboxylase) but not to hormone-sensitive lipase. This allows selective regulation of different metabolic pathways. Choice A is incorrect because the question refers to liver cells, not tissue differences. Choice B is incorrect because while other phosphatases may be involved, the primary issue is PP1 targeting. Choice D is incorrect because insulin does regulate hormone-sensitive lipase, but through different mechanisms than direct PP1 dephosphorylation.
- McArdle disease is caused by a deficiency in the muscle isozyme of glycogen phosphorylase. A patient with this condition undertakes vigorous anaerobic exercise. Which of the following findings would be most consistent with their condition immediately following the exercise?
Answer: Abnormally low blood lactate levels despite signs of muscle fatigue and cramping.
When you encounter questions about glycogen storage diseases, focus on the specific enzymatic defect and trace its metabolic consequences through the affected pathways.
McArdle disease involves a deficiency in muscle glycogen phosphorylase, the enzyme that breaks down glycogen into glucose-1-phosphate for glycolysis. During vigorous anaerobic exercise, muscles normally rely heavily on glycogen breakdown to fuel ATP production through glycolysis, which produces lactate as an end product.
In McArdle disease, muscles cannot access their glycogen stores effectively. This creates a metabolic bottleneck: the muscle desperately needs glucose for energy but cannot break down its primary stored fuel source. The muscle becomes fatigued and cramps due to inadequate ATP production, but paradoxically produces little lactate because glycolysis is severely limited by the lack of glucose substrate. This explains why option A is correct - you see the clinical signs of energy deficit (fatigue and cramping) without the expected biochemical marker of anaerobic metabolism (elevated lactate).
Option B is wrong because lactate levels are actually decreased, not elevated, due to impaired glycolysis. Option C incorrectly suggests muscle glycogen normally buffers blood glucose - muscle glycogen is metabolically separate from blood glucose regulation and cannot be released into circulation. Option D is incorrect because glucose levels in muscle would be low, not high, since the cells cannot generate glucose-1-phosphate from glycogen.
Remember: in glycogen storage diseases, always consider what happens both upstream and downstream of the blocked enzyme to predict the full clinical picture.
- After consuming a large carbohydrate-rich meal, hormonal changes signal the liver to switch from glucose production to glucose storage. Which of the following events is the least direct contributor to the activation of glycogen synthase in hepatocytes in this state?
Answer: Suppression of fatty acid oxidation due to high levels of malonyl-CoA inhibiting carnitine acyltransferase I.
Choices A, B, and C are all direct molecular mechanisms that increase the activity of glycogen synthase. (A) Insulin activates PP1, which directly dephosphorylates and activates the synthase. (C) High glucose influx leads to high G6P, a key allosteric activator. (B) Active phosphorylase 'a' inhibits PP1; inactivating phosphorylase removes this inhibition. In contrast, (D) describes the inhibition of beta-oxidation. While this is a critical part of the overall fed-state metabolic program (shifting from fat burning to fat/glycogen storage), it does not directly regulate the activity of the glycogen synthase enzyme itself.
- Protein phosphatase 1 (PP1) is central to promoting glycogen synthesis. Its activity is inhibited when PKA phosphorylates an inhibitor subunit, which then binds to PP1. Consider a mutation that prevents this inhibitor subunit from being phosphorylated by PKA. How would this mutation affect liver glycogen metabolism in response to glucagon?
Answer: The glucagon signal would be dampened, as PP1 would remain active and oppose the actions of phosphorylase kinase.
When analyzing glycogen metabolism questions, focus on the opposing regulatory mechanisms that control synthesis versus breakdown, and how hormonal signals coordinate these pathways through phosphorylation cascades.
Let's trace through the normal glucagon signaling pathway: Glucagon activates PKA, which phosphorylates multiple targets to promote glycogen breakdown. One key target is the PP1 inhibitor subunit. When PKA phosphorylates this inhibitor, it binds to and inactivates PP1. Since PP1 normally promotes glycogen synthesis by dephosphorylating (activating) glycogen synthase and dephosphorylating (inactivating) phosphorylase kinase, shutting down PP1 is essential for effective glycogenolysis.
With the mutation preventing inhibitor phosphorylation, PP1 remains active even when glucagon signals for glycogen breakdown. Active PP1 continues dephosphorylating phosphorylase kinase (inactivating it) and maintaining glycogen synthase in its active state. This creates a situation where the glucagon signal is significantly weakened because PP1 actively opposes the phosphorylation events that PKA is trying to establish.
Answer choice A incorrectly suggests signal amplification when the opposite occurs. Choice B is wrong because the cell isn't locked in synthesis mode - PKA can still phosphorylate other targets, just not effectively. Choice C misrepresents the situation as complete unresponsiveness rather than dampened signaling.
The correct answer is D - the glucagon response is dampened because constitutively active PP1 works against PKA's phosphorylation efforts.
Study tip: For glycogen regulation questions, always map out which enzymes are active/inactive in each metabolic state and identify the phosphatases and kinases controlling those switches.
- When skeletal muscle breaks down glycogen to fuel contraction, the primary product is glucose-1-phosphate (G1P), which is then converted to glucose-6-phosphate (G6P). What is the key bioenergetic advantage of using glycogen-derived glucose for glycolysis compared to starting with free glucose from the blood?
Answer: It saves one molecule of ATP per glucose unit, resulting in a net yield of three ATP from anaerobic glycolysis instead of two.
Free glucose entering a cell must be phosphorylated to glucose-6-phosphate by hexokinase, a reaction that consumes one ATP. When starting from glycogen, the glucose unit is released as G1P and converted to G6P, bypassing the hexokinase step. This means the 'investment' phase of glycolysis only costs one ATP (at the PFK-1 step) instead of two. Therefore, the net gain from anaerobic glycolysis is 3 ATP per glucose unit from glycogen, versus 2 ATP from free blood glucose.
- During prolonged fasting, glucagon levels remain elevated for several hours. A student hypothesizes that glycogen phosphorylase should be maximally active throughout this period. However, hepatic glucose output gradually decreases over 12-18 hours despite continued glucagon signaling. Which of the following best explains this apparent contradiction?
Answer: Progressive depletion of hepatic glycogen stores reduces substrate availability for phosphorylase despite continued enzyme activation
Even with maximal enzyme activation, glycogen breakdown must eventually slow as glycogen stores become depleted. Hepatic glycogen stores are finite and can be substantially depleted within 12-18 hours of fasting. Phosphorylase activity depends on both enzyme activation state AND substrate availability. Choice A is incorrect because glucagon signaling remains effective during prolonged fasting, though some desensitization may occur, it's not the primary limitation. Choice C is incorrect because cortisol actually enhances rather than inhibits gluconeogenic capacity. Choice D is incorrect because glucose-6-phosphate inhibits glycogen synthase, not phosphorylase, and G6P levels would be kept low by glucose-6-phosphatase activity during glucose output.
- A new experimental drug is found to be a potent allosteric inhibitor of the liver isozyme of glycogen phosphorylase 'a'. If this drug is administered to an individual during a period of fasting, what is the most likely immediate metabolic consequence?
Answer: A decrease in the rate of glucose release from the liver, potentially leading to hypoglycemia.
When you encounter questions about enzyme inhibition during metabolic states like fasting, focus on the primary metabolic pathway being affected and the immediate consequences before compensatory mechanisms kick in.
Glycogen phosphorylase 'a' is the active form of the key enzyme that breaks down liver glycogen into glucose during fasting. This process, called glycogenolysis, is essential for maintaining blood glucose levels when you're not eating. The liver acts as the body's glucose buffer, releasing stored glucose to keep blood sugar stable.
If an allosteric inhibitor blocks this enzyme, glycogenolysis in the liver essentially stops. Since the liver can no longer break down its glycogen stores to release glucose into the bloodstream, glucose output from the liver drops dramatically. During fasting, when the body depends heavily on this hepatic glucose release, this reduction would likely cause blood glucose levels to fall, potentially leading to hypoglycemia. This makes option D correct.
Option A is wrong because while gluconeogenesis might eventually compensate, it's a slower process and wouldn't immediately prevent the drop in glucose from halted glycogenolysis. Option B incorrectly assumes muscle glycogenolysis significantly contributes to blood glucose—muscle primarily uses its glycogen stores for its own energy needs. Option C misunderstands the pathway: inhibiting glycogen phosphorylase would actually decrease glucose-1-phosphate production, not increase it, since this enzyme is what produces glucose-1-phosphate from glycogen.
Remember: always consider the immediate, direct effects of enzyme inhibition before thinking about compensatory mechanisms, which take time to activate.
- A patient with Pompe disease (lysosomal α-1,4-glucosidase deficiency) shows progressive muscle weakness. Muscle biopsy reveals enlarged lysosomes filled with glycogen, while cytosolic glycogen levels appear normal. Despite normal cytosolic glycogen phosphorylase activity, the patient experiences exercise intolerance. Which statement best explains the metabolic basis of the exercise intolerance?
Answer: Accumulated lysosomal glycogen cannot be mobilized during exercise, reducing the total glycogen pool available for energy production
In Pompe disease, glycogen accumulates in lysosomes because α-1,4-glucosidase (acid maltase) cannot break it down. This represents a significant fraction of total muscle glycogen that becomes metabolically unavailable. During exercise, muscles cannot access this trapped glycogen pool for energy production, effectively reducing their total glycogen reserves even though cytosolic glycogen metabolism appears normal. Choice B is incorrect because while autophagy may be affected, this is not the primary cause of exercise intolerance. Choice C is incorrect because the exercise intolerance is primarily metabolic, not mechanical. Choice D is incorrect because lysosomal dysfunction doesn't directly impair calcium-dependent activation of cytosolic phosphorylase.
- A patient presents with severe fasting hypoglycemia, hepatomegaly due to excess glycogen storage, and lactic acidosis. The structure of the stored liver glycogen appears normal with typical branching. Which enzymatic deficiency best explains this collection of symptoms?
Answer: Glucose-6-phosphatase (von Gierke's disease), because its absence traps glucose-6-phosphate in the liver.
A deficiency in glucose-6-phosphatase (G6Pase) prevents the liver from releasing free glucose into the blood, causing severe fasting hypoglycemia. The resulting accumulation of glucose-6-phosphate allosterically activates glycogen synthase, leading to massive glycogen storage (hepatomegaly), and also shunts excess G6P into glycolysis, producing excess pyruvate and lactate (lactic acidosis). The other deficiencies do not account for all three symptoms; for example, a phosphorylase deficiency wouldn't cause significant lactic acidosis, and branching/debranching enzyme defects would alter glycogen structure.
- A biochemist measures the kinetic parameters of purified glycogen phosphorylase under different conditions. In the presence of AMP, the enzyme shows a Km for glycogen of 0.8 mg/mL and Vmax of 150 μmol/min/mg protein. When AMP is replaced with ATP at the same concentration, Km increases to 2.1 mg/mL and Vmax decreases to 95 μmol/min/mg protein. What type of regulation does this data demonstrate?
Answer: Mixed-type allosteric regulation, where ATP binding decreases both substrate affinity and maximum catalytic rate compared to AMP
When you encounter enzyme kinetics questions involving different effector molecules, you're dealing with allosteric regulation rather than simple competitive inhibition. The key is analyzing how both Km and Vmax change together.
In this glycogen phosphorylase example, AMP acts as an allosteric activator while ATP serves as an allosteric inhibitor. With AMP present, you see favorable kinetics: low Km (0.8 mg/mL, indicating high substrate affinity) and high Vmax (150 μmol/min/mg). When ATP replaces AMP, both parameters worsen significantly - Km increases to 2.1 mg/mL (decreased substrate affinity) and Vmax drops to 95 μmol/min/mg (reduced catalytic efficiency). This dual effect on both binding and catalysis is characteristic of mixed-type allosteric regulation, making D correct.
Option A misidentifies this as competitive inhibition, but competitive inhibitors only affect Km while leaving Vmax unchanged. Here, Vmax clearly decreases. Option B suggests non-competitive inhibition, which would decrease Vmax but leave Km relatively unchanged - the opposite of what you observe. Option C proposes uncompetitive inhibition, where both parameters decrease proportionally, but here Km increases while Vmax decreases.
The physiological logic supports this: AMP signals low energy (favoring glycogen breakdown), while ATP signals high energy (inhibiting further glucose release). Both bind to allosteric sites, not the active site.
Study tip: In allosteric regulation questions, always check if both Km and Vmax change significantly - this immediately rules out simple competitive/non-competitive models and points toward mixed-type allosteric effects.
- A researcher studying glycogen metabolism adds fluoride ion to a liver cell extract containing active glycogen phosphorylase. The fluoride treatment results in rapid cessation of glycogen breakdown within 5 minutes, even though the phosphorylase remains in its phosphorylated, active form. Western blot analysis confirms that protein phosphatase activity is also inhibited by fluoride. What is the most likely mechanism explaining this result?
Answer: Fluoride inhibits enolase in glycolysis, causing glucose-6-phosphate accumulation that allosterically inhibits glycogen phosphorylase
When you encounter questions about metabolic regulation, focus on how pathways interconnect and how metabolites from one pathway can regulate another through allosteric effects.
Fluoride's primary metabolic effect occurs in glycolysis, where it inhibits enolase, the enzyme that converts 2-phosphoglycerate to phosphoenolpyruvate. When enolase is blocked, glycolytic intermediates accumulate upstream, particularly glucose-6-phosphate. This glucose-6-phosphate buildup creates a powerful allosteric inhibition of glycogen phosphorylase, effectively shutting down glycogen breakdown even though the enzyme remains in its active, phosphorylated form. This explains why glycogen breakdown stops despite the phosphorylase appearing structurally active.
Option A is incorrect because fluoride doesn't directly bind to glycogen phosphorylase's active site. Option B misidentifies the enzyme affected—while glucose-6-phosphatase is involved in glucose metabolism, fluoride's primary target is enolase, not glucose-6-phosphatase. Option C suggests fluoride chelates metal ions needed by phosphorylase, but glycogen phosphorylase doesn't require metal cofactors for its catalytic mechanism, and this wouldn't explain the specific pattern observed.
The key insight is recognizing that fluoride's inhibition of enolase creates a metabolic traffic jam, backing up glucose-6-phosphate, which then allosterically inhibits the very pathway (glycogenolysis) that would normally produce more glucose-6-phosphate.
Remember: metabolic pathways are interconnected networks. When studying enzyme inhibitors, always consider both direct effects and downstream consequences that might regulate other pathways through allosteric mechanisms.
- In a healthy individual, a prolonged period of fasting leads to a low insulin-to-glucagon ratio. In hepatocytes, what is the expected covalent modification state and resulting activity of glycogen synthase and glycogen phosphorylase?
Answer: Glycogen synthase is phosphorylated and inactive; glycogen phosphorylase is phosphorylated and active.
During fasting, glucagon signaling activates Protein Kinase A (PKA). PKA phosphorylates and inactivates glycogen synthase. PKA also initiates a cascade that phosphorylates and activates glycogen phosphorylase. This ensures that glycogen synthesis is turned off and glycogen breakdown is turned on to release glucose into the blood.
- The binding of glucagon to its receptor on hepatocytes activates protein kinase A (PKA). Which of the following best describes the immediate downstream effects of PKA that ensure a coordinated shift from glycogen synthesis to degradation?
Answer: PKA activates phosphorylase kinase, which activates glycogen phosphorylase; PKA also directly phosphorylates and inactivates glycogen synthase.
PKA orchestrates reciprocal regulation. It does not directly phosphorylate glycogen phosphorylase. Instead, it phosphorylates and activates another enzyme, phosphorylase kinase. Phosphorylase kinase then phosphorylates and activates glycogen phosphorylase (stimulating breakdown). Simultaneously, PKA directly phosphorylates glycogen synthase, which inactivates it (inhibiting synthesis). This ensures a coordinated response.
- A patient with McArdle disease (muscle glycogen phosphorylase deficiency) begins moderate exercise after an overnight fast. Muscle glycogen levels are initially normal due to compensation during the fasting period. Which of the following best explains the primary metabolic consequence during the first 10 minutes of exercise?
Answer: Rapid depletion of muscle ATP and phosphocreatine stores due to inability to mobilize stored muscle glycogen for glycolysis
McArdle disease involves deficiency of muscle glycogen phosphorylase, preventing breakdown of muscle glycogen. During early exercise, muscles normally rely heavily on glycogen breakdown for rapid ATP production through glycolysis. Without this pathway, ATP and phosphocreatine stores deplete rapidly since fatty acid oxidation is too slow to meet immediate high energy demands. Choice A is incorrect because increased glucose uptake cannot fully compensate for the loss of the large glycogen store, and lactate production would actually be impaired. Choice C is incorrect because fatty acid oxidation is too slow for immediate energy needs in early exercise. Choice D is incorrect because muscle gluconeogenesis is not a significant source of glucose for local muscle metabolism.
- Glycogen synthesis is initiated by glycogenin, a protein that both serves as a primer and catalyzes the formation of the initial short glucose chain. A mutation in the gene for glycogenin completely abolishes its glucosyltransferase activity. What is the most direct and immediate consequence of this defect?
Answer: De novo synthesis of new glycogen molecules cannot occur, although breakdown of existing molecules is unaffected.
When you encounter questions about glycogen metabolism, focus on the sequential steps required for synthesis and how each enzyme has a specific role that cannot be substituted by others.
Glycogenin is essential for initiating glycogen synthesis because it serves dual functions: acting as a protein primer and catalyzing the formation of the first 8-10 glucose residues through its glucosyltransferase activity. Without functional glucosyltransferase activity, glycogenin cannot create the initial glucose chain that glycogen synthase requires to begin elongation. Since glycogen synthase can only add glucose residues to existing chains (it cannot start synthesis de novo), the complete loss of glycogenin's catalytic function prevents any new glycogen molecules from forming. However, existing glycogen molecules remain structurally intact and can still be broken down by glycogen phosphorylase, which works independently of glycogenin.
Answer A correctly identifies this fundamental requirement - new glycogen synthesis is impossible without functional glycogenin, while breakdown remains unaffected. Answer B incorrectly suggests existing glycogen can't be elongated; glycogen synthase can still extend pre-existing molecules. Answer C is wrong because glycogen synthase cannot self-prime at any efficiency - it absolutely requires an existing glucose chain. Answer D confuses glycogenin's role with that of the branching enzyme; glycogenin doesn't affect branching patterns.
Remember that glycogen synthesis requires a strict sequence: glycogenin creates the primer, glycogen synthase elongates it, and branching enzyme adds branches. Each step depends on the previous one, so identify which specific step is disrupted in the question.
